Results
Latest quarterly results
Companies that reported quarterly results recently, newest first. Each row compares the reported quarter with the same quarter a year earlier. Figures in USD; revenue and net income in millions.
SectorAll 3892Healthcare 878Financial Services 629Technology 560Industrials 517Consumer Cyclical 330Basic Materials 232Energy 196Communication Services 168Real Estate 161Consumer Defensive 134Utilities 87
| Company | Sector | Reported | Quarter | Revenue | Rev. YoY | Net income | NI YoY | EPS | EPS YoY | Op. margin | Margin chg. | Market cap |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ETONEton Pharmaceuticals, Inc. | Healthcare | Nov 5 | Sep '26 | $58.0M | +163.6% | $35.0M | n/m | $1.06 | n/m | 39.7% | +45.8 pp | $1.8B |
| AGIOAgios Pharmaceuticals, Inc. | Healthcare | Nov 5 | Sep '26 | $55.0M | +323.1% | −$65.0M | n/m | −$1.09 | n/m | -139.3% | +768.0 pp | $1.8B |
| TRLVTrulieve Cannabis Corp. Subordinate Voting Shares | Healthcare | Nov 5 | Sep '26pending | $230M† | −20.1% | — | — | — | — | — | — | $1.7B |
| XRAYDENTSPLY SIRONA Inc. | Healthcare | Nov 5 | Sep '26 | $836M | −7.5% | −$2.0M | n/m | −$0.01 | n/m | 4.4% | −0.7 pp | $1.7B |
| CERTCertara, Inc. | Healthcare | Nov 5 | Sep '26 | $95.0M | −9.5% | $6.0M | +200.0% | $0.04 | +300.0% | 2.5% | −0.4 pp | $1.7B |
| SNDASonida Senior Living, Inc. | Healthcare | Nov 5 | Sep '26 | $210M | +114.3% | −$34.0M | n/m | −$0.72 | n/m | -9.3% | −4.6 pp | $1.6B |
| ANIPANI Pharmaceuticals, Inc. | Healthcare | Nov 5 | Sep '26 | $291M | +27.6% | $35.0M | +45.8% | $1.51 | +33.6% | 18.0% | +8.0 pp | $1.6B |
| ASTHAstrana Health Inc. | Healthcare | Nov 5 | Sep '26 | $1.02B | +7.1% | $13.0M | n/m | $0.26 | +2,500% | 3.9% | +1.9 pp | $1.6B |
| SRPTSarepta Therapeutics, Inc. | Healthcare | Nov 5 | Sep '26 | $381M | −4.5% | −$28.0M | n/m | −$0.27 | n/m | -2.4% | +23.5 pp | $1.6B |
| ENOVEnovis Corporation | Healthcare | Nov 5 | Sep '26 | $559M | +1.8% | $3.0M | n/m | $0.06 | n/m | 0.6% | −1.1 pp | $1.6B |
| AMNAMN Healthcare Services Inc | Healthcare | Nov 5 | Sep '26 | $717M | +13.1% | $33.0M | +13.8% | $0.83 | +9.2% | 7.0% | +5.7 pp | $1.5B |
| PCRXPacira BioSciences, Inc. | Healthcare | Nov 5 | Sep '26 | $177M | −1.7% | $29.0M | +480.0% | $0.70 | +483.3% | 12.6% | +9.1 pp | $1.5B |
| NTLAIntellia Therapeutics, Inc. | Healthcare | Nov 5 | Sep '26 | $7.0M | −50.0% | −$127M | n/m | −$0.91 | n/m | — | — | $1.4B |
| NVAXNovavax, Inc. | Healthcare | Nov 5 | Sep '26 | $68.0M | −2.9% | −$31.0M | n/m | −$0.19 | n/m | -45.8% | +206.9 pp | $1.3B |
| MNKDMannKind Corporation | Healthcare | Nov 5 | Sep '26 | $102M | +24.4% | −$23.0M | −387.5% | −$0.07 | −333.3% | -2.1% | −25.0 pp | $1.3B |
| LBRXLB Pharmaceuticals Inc | Healthcare | Nov 5 | Sep '26 | $0.0M | n/m | −$59.0M | n/m | −$1.79 | n/m | — | — | $1.3B |
| AMPHAmphastar Pharmaceuticals, Inc. | Healthcare | Nov 5 | Sep '26 | $208M | +8.3% | $38.0M | +123.5% | $0.87 | +135.1% | 24.5% | +11.3 pp | $1.2B |
| NUTXNutex Health Inc. | Healthcare | Nov 5 | Sep '26 | $218M | −18.7% | $40.0M | −27.3% | $5.71 | −26.4% | 35.4% | −13.3 pp | $1.2B |
| TNDMTandem Diabetes Care, Inc. | Healthcare | Nov 5 | Sep '26 | $284M | +14.1% | −$7.0M | n/m | −$0.10 | n/m | -0.8% | +7.2 pp | $1.2B |
| CRONCronos Group Inc. - Common Share | Healthcare | Nov 5 | Sep '26 | $63.0M | +75.0% | $14.0M | −46.2% | $0.04 | −42.9% | 14.2% | +15.6 pp | $1.2B |
| CSTLCastle Biosciences, Inc. | Healthcare | Nov 5 | Sep '26 | $103M | +24.1% | −$4.0M | n/m | −$0.13 | n/m | -2.6% | +5.5 pp | $1.0B |
| VSTMVerastem, Inc. | Healthcare | Nov 5 | Sep '26 | $24.0M | +118.2% | −$75.0M | n/m | −$0.74 | n/m | -313.3% | +48.9 pp | $934M |
| AORTArtivion, Inc. | Healthcare | Nov 5 | Sep '26 | $124M | +9.7% | −$8.0M | −214.3% | −$0.16 | −223.1% | 2.4% | −8.7 pp | $891M |
| OMDAOmada Health, Inc. | Healthcare | Nov 5 | Sep '26 | $91.0M | +33.8% | −$2.0M | n/m | −$0.04 | n/m | 5.3% | +9.0 pp | $873M |
| CRVSCorvus Pharmaceuticals, Inc. | Healthcare | Nov 5 | Sep '26 | $0.0M | n/m | −$20.0M | n/m | −$0.22 | n/m | — | — | $858M |
| RIGLRigel Pharmaceuticals, Inc. | Healthcare | Nov 5 | Sep '26 | $81.0M | +17.4% | $13.0M | −53.6% | $0.65 | −55.5% | 21.1% | −19.8 pp | $808M |
| IRWDIronwood Pharmaceuticals, Inc. | Healthcare | Nov 5 | Sep '26 | $133M | +9.0% | $60.0M | +50.0% | $0.36 | +56.5% | 70.0% | +6.4 pp | $806M |
| COLLCollegium Pharmaceutical, Inc. | Healthcare | Nov 5 | Sep '26 | $216M | +3.3% | $22.0M | −31.2% | $0.60 | −28.6% | 11.9% | −18.4 pp | $794M |
| LXRXLexicon Pharmaceuticals, Inc. | Healthcare | Nov 5 | Sep '26 | $11.0M | −21.4% | −$14.0M | n/m | −$0.03 | n/m | -128.8% | −42.9 pp | $793M |
| GLUEMonte Rosa Therapeutics, Inc. | Healthcare | Nov 5 | Sep '26 | $54.0M | +315.4% | $3.0M | n/m | $0.03 | n/m | -3.6% | +254.7 pp | $775M |
| FLGTFulgent Genetics, Inc. | Healthcare | Nov 5 | Sep '26 | $90.0M | +7.1% | −$13.0M | n/m | −$0.48 | n/m | -24.9% | −6.7 pp | $676M |
| JANXJanux Therapeutics, Inc. | Healthcare | Nov 5 | Sep '26 | $9.0M | −10.0% | −$22.0M | n/m | −$0.34 | n/m | -336.5% | +16.0 pp | $655M |
| CLYMClimb Bio, Inc. | Healthcare | Nov 5 | Sep '26 | $0.0M | n/m | −$15.0M | n/m | −$0.18 | n/m | — | — | $574M |
| SANASana Biotechnology, Inc. | Healthcare | Nov 5 | Sep '26 | $0.0M | n/m | $20.0M | n/m | $0.07 | n/m | — | — | $563M |
| DNAGinkgo Bioworks Holdings, Inc. | Healthcare | Nov 5 | Sep '26 | $28.0M | −28.2% | −$41.0M | n/m | −$0.64 | n/m | -157.5% | +74.3 pp | $539M |
| ACRSAclaris Therapeutics, Inc. | Healthcare | Nov 5 | Sep '26 | $1.0M | −66.7% | −$19.0M | n/m | −$0.12 | n/m | — | — | $536M |
| EVHEvolent Health, Inc | Healthcare | Nov 5 | Sep '26 | $725M | +51.0% | −$24.0M | n/m | −$0.21 | n/m | 0.8% | +0.7 pp | $520M |
| GYREGyre Therapeutics, Inc. | Healthcare | Nov 5 | Sep '26 | $33.0M | +6.5% | −$4.0M | −200.0% | −$0.04 | −233.3% | -4.6% | −27.3 pp | $499M |
| RGNXREGENXBIO Inc. | Healthcare | Nov 5 | Sep '26 | $9.0M | n/m | −$41.0M | n/m | −$0.62 | n/m | -387.8% | — | $479M |
| STTKShattuck Labs, Inc. | Healthcare | Nov 5 | Sep '26 | $0.0M | −100.0% | −$25.0M | n/m | −$0.14 | n/m | — | — | $467M |
| SIShoulder Innovations, Inc. | Healthcare | Nov 5 | Sep '26 | $16.0M | +33.3% | −$7.0M | n/m | −$0.34 | n/m | -46.9% | +18.1 pp | $430M |
| PRTAProthena Corporation plc | Healthcare | Nov 5 | Sep '26 | $1.0M | −50.0% | −$17.0M | n/m | −$0.32 | n/m | — | — | $424M |
| CTMXCytomX Therapeutics, Inc. | Healthcare | Nov 5 | Sep '26 | $2.0M | −66.7% | −$20.0M | n/m | −$0.09 | n/m | — | — | $423M |
| MOBIMobia Medical, Inc. | Healthcare | Nov 5 | Sep '26 | $16.0M | — | −$17.0M | — | −$0.52 | — | -118.7% | — | $420M |
| AVTXAvalo Therapeutics, Inc. | Healthcare | Nov 5 | Sep '26 | $0.0M | n/m | −$19.0M | n/m | −$0.34 | n/m | — | — | $412M |
| TECXTectonic Therapeutic, Inc. | Healthcare | Nov 5 | Sep '26 | $0.0M | n/m | −$21.0M | n/m | −$1.08 | n/m | — | — | $393M |
| RCELAvita Medical, Inc. | Healthcare | Nov 5 | Sep '26 | $26.0M | +52.9% | −$6.0M | n/m | −$0.20 | n/m | -10.1% | +43.6 pp | $392M |
| RZLTRezolute, Inc. - Common Stock (NV) | Healthcare | Nov 5 | Sep '26 | $0.0M | n/m | −$18.0M | n/m | −$0.18 | n/m | — | — | $388M |
| ALECAlector, Inc. | Healthcare | Nov 5 | Sep '26 | $163M | +5,333% | $125M | n/m | $1.11 | n/m | 76.0% | — | $381M |
| PBYIPuma Biotechnology Inc | Healthcare | Nov 5 | Sep '26 | $55.0M | +1.9% | $6.0M | −33.3% | $0.11 | −35.3% | 9.6% | −8.0 pp | $369M |
- Report dates come from the earnings calendar (dates loaded Oct 4 to Dec 9); figures come from the quarterly statements stored for each company. Click a ticker for its full statements.
- YoY compares the reported quarter with the same quarter a year earlier. n/m (not meaningful) means the year-earlier figure was zero or negative, so a percentage change would not describe it. Margin change is in percentage points.
- pending: the company has reported, but that quarter is not in our statements yet. Revenue marked † is the announced figure from the earnings calendar; the other columns fill in once the statements update.
Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.